Lattanzi, R.; Maftei, D.; Petrella, C.; Pieri, M.; Sancesario, G.; Schirinzi, T.; Bernardini, S.; Barbato, C.; Ralli, M.; Greco, A.;
et al. Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer’s Disease: From Animal Models to the Human Pathology. Cells 2019, 8, 1430.
https://doi.org/10.3390/cells8111430
AMA Style
Lattanzi R, Maftei D, Petrella C, Pieri M, Sancesario G, Schirinzi T, Bernardini S, Barbato C, Ralli M, Greco A,
et al. Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer’s Disease: From Animal Models to the Human Pathology. Cells. 2019; 8(11):1430.
https://doi.org/10.3390/cells8111430
Chicago/Turabian Style
Lattanzi, Roberta, Daniela Maftei, Carla Petrella, Massimo Pieri, Giulia Sancesario, Tommaso Schirinzi, Sergio Bernardini, Christian Barbato, Massimo Ralli, Antonio Greco,
and et al. 2019. "Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer’s Disease: From Animal Models to the Human Pathology" Cells 8, no. 11: 1430.
https://doi.org/10.3390/cells8111430
APA Style
Lattanzi, R., Maftei, D., Petrella, C., Pieri, M., Sancesario, G., Schirinzi, T., Bernardini, S., Barbato, C., Ralli, M., Greco, A., Possenti, R., Sancesario, G., & Severini, C.
(2019). Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer’s Disease: From Animal Models to the Human Pathology. Cells, 8(11), 1430.
https://doi.org/10.3390/cells8111430